Meyrick succeeding CMO Harris at radiopharma ITM
Plus: ALX hires Dillon and updates from Obsidian, YS and more
ITM Isotope Technologies Munich SE hired Danielle Meyrick to succeed CMO Philip Harris, who is retiring. Meyrick was CSO, research and insights at GenesisCare Inc. Temasek led a €255 million ($272.6 million) equity investment in the radiopharmaceuticals company last June.
CD47 company ALX Oncology Holdings Inc. (NASDAQ:ALXO) hired Allison Dillon as CBO. Dillon was SVP, commercial and portfolio strategy at Calithera Biosciences Inc. ...